STELLATE THERAPEUTICS Trademark

Trademark Overview

On Wednesday, January 15, 2020, a trademark application was filed for STELLATE THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the STELLATE THERAPEUTICS trademark a serial number of 88760517. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, February 27, 2023. This trademark is owned by Amabiotics Inc.. The STELLATE THERAPEUTICS trademark is filed in the Pharmaceutical Products category with the following description:

pharmaceutical preparations and therapeutics for the treatment of neurodegenerative diseases and disorders, neurological diseases and disorders, microbiome-related conditions, diseases and disorders related to the gut-brain axis, Alzheimer's disease, Parkinson's disease, Ataxia, Huntington's disease, and amyotrophic lateral sclerosis (ALS)
stellate therapeutics

General Information

Serial Number88760517
Word MarkSTELLATE THERAPEUTICS
Filing DateWednesday, January 15, 2020
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, February 27, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 26, 2020

Trademark Statements

Goods and Servicespharmaceutical preparations and therapeutics for the treatment of neurodegenerative diseases and disorders, neurological diseases and disorders, microbiome-related conditions, diseases and disorders related to the gut-brain axis, Alzheimer's disease, Parkinson's disease, Ataxia, Huntington's disease, and amyotrophic lateral sclerosis (ALS)
Disclaimer with Predetermined Text"THERAPEUTICS"

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, January 22, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameSTELLATE THERAPEUTICS INC.
Party Type22 - New Owner After Publication
Legal Entity Type03 - Corporation
AddressNEW YORK, NY 10013
Party NameSTELLATE THERAPEUTICS INC.
Party Type21 - New Owner After Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 10013
Party NameAmabiotics Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 10013
Party NameAmabiotics Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10013

Trademark Events

Event DateEvent Description
Monday, February 27, 2023ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, February 27, 2023ABANDONMENT - NO USE STATEMENT FILED
Saturday, July 9, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, July 7, 2022SOU EXTENSION 4 GRANTED
Thursday, July 7, 2022SOU EXTENSION 4 FILED
Thursday, July 7, 2022SOU TEAS EXTENSION RECEIVED
Saturday, March 5, 2022CORRECTED NOA E-MAILED
Thursday, March 3, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, March 2, 2022SOU EXTENSION 3 GRANTED
Friday, January 21, 2022SOU EXTENSION 3 FILED
Wednesday, March 2, 2022DIVISIONAL PROCESSING COMPLETE
Friday, January 21, 2022DIVISIONAL REQUEST RECEIVED
Friday, January 21, 2022TEAS REQUEST TO DIVIDE RECEIVED
Friday, January 21, 2022SOU TEAS EXTENSION RECEIVED
Friday, July 16, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, July 14, 2021SOU EXTENSION 2 GRANTED
Wednesday, July 14, 2021SOU EXTENSION 2 FILED
Wednesday, July 14, 2021SOU TEAS EXTENSION RECEIVED
Thursday, February 4, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, February 3, 2021AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Wednesday, February 3, 2021SOU EXTENSION 1 GRANTED
Friday, January 8, 2021SOU EXTENSION 1 FILED
Thursday, January 28, 2021CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, January 8, 2021SOU TEAS EXTENSION RECEIVED
Tuesday, July 21, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, May 26, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 26, 2020PUBLISHED FOR OPPOSITION
Wednesday, May 6, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, April 17, 2020ASSIGNED TO LIE
Tuesday, April 7, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, April 7, 2020EXAMINER'S AMENDMENT ENTERED
Tuesday, April 7, 2020NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, April 7, 2020EXAMINERS AMENDMENT E-MAILED
Tuesday, April 7, 2020EXAMINERS AMENDMENT -WRITTEN
Thursday, April 2, 2020ASSIGNED TO EXAMINER
Wednesday, January 22, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, January 18, 2020NEW APPLICATION ENTERED

Related Keywords

therapeutics stellate disease disorders diseases related sclerosis alzheimer parkinson ataxia huntington axis